Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 08 04:00PM ET
107.20
Dollar change
-0.43
Percentage change
-0.40
%
Index- P/E34.76 EPS (ttm)3.08 Insider Own0.02% Shs Outstand3.38B Perf Week-4.23%
Market Cap357.88B Forward P/E26.09 EPS next Y4.11 Insider Trans0.00% Shs Float3.34B Perf Month-8.79%
Income13.78B PEG3.16 EPS next Q0.88 Inst Own10.06% Short Float0.19% Perf Quarter-17.47%
Sales39.33B P/S9.10 EPS this Y21.57% Inst Trans-0.07% Short Ratio1.48 Perf Half Y-16.52%
Book/sh3.66 P/B29.26 EPS next Y24.55% ROA26.99% Short Interest6.36M Perf Year5.35%
Cash/sh3.36 P/C31.92 EPS next 5Y11.00% ROE88.20% 52W Range94.73 - 148.15 Perf YTD3.62%
Dividend Est.1.60 (1.49%) P/FCF31.58 EPS past 5Y16.48% ROI53.52% 52W High-27.64% Beta0.41
Dividend TTM1.45 (1.35%) Quick Ratio0.75 Sales past 5Y14.25% Gross Margin84.66% 52W Low13.16% ATR (14)2.52
Dividend Ex-DateAug 16, 2024 Current Ratio0.94 EPS Y/Y TTM28.06% Oper. Margin43.87% RSI (14)29.59 Volatility2.08% 1.68%
Employees63370 Debt/Eq0.47 Sales Y/Y TTM27.73% Profit Margin35.03% Recom1.97 Target Price143.22
Option/ShortYes / Yes LT Debt/Eq0.43 EPS Q/Q23.29% Payout36.03% Rel Volume1.21 Prev Close107.63
Sales Surprise-2.85% EPS Surprise0.19% Sales Q/Q22.49% EarningsNov 06 BMO Avg Volume4.30M Price107.20
SMA20-5.56% SMA50-11.71% SMA200-16.46% Trades Volume5,216,878 Change-0.40%
Date Action Analyst Rating Change Price Target Change
May-30-24Initiated Goldman Buy $156
Apr-12-24Initiated BMO Capital Markets Outperform $163
Jan-23-24Initiated Morgan Stanley Overweight $120
Jan-16-24Resumed UBS Neutral
Dec-01-23Initiated Cantor Fitzgerald Overweight $120
Oct-02-23Initiated Argus Buy $110
Jul-14-23Initiated HSBC Securities Buy
Jul-15-22Upgrade Morgan Stanley Equal-Weight → Overweight
Jun-28-22Downgrade UBS Neutral → Sell
Jun-27-22Upgrade Exane BNP Paribas Underperform → Neutral
Today 05:45AM
05:15AM
Nov-09-24 09:00AM
Nov-08-24 04:22PM
03:51PM
03:47PM Loading…
03:47PM
11:12AM
09:36AM
05:00AM
Nov-07-24 01:38PM
12:27PM
12:27PM
10:13AM
07:01AM
06:54AM
02:06AM Loading…
02:06AM
Nov-06-24 04:08PM
02:43PM
02:10PM
12:26PM
12:21PM
12:04PM
11:55AM
11:45AM
11:29AM
11:05AM
10:33AM
09:48AM
09:39AM
08:53AM
08:40AM Loading…
08:40AM
07:50AM
07:50AM
07:41AM
07:01AM
05:38AM
05:32AM
05:00AM
03:34AM
02:59AM
01:41AM
01:36AM
Nov-05-24 05:15PM
04:30PM
04:11PM
04:07PM
03:18PM
02:51PM
12:12PM
10:50AM
10:00AM
08:37AM
08:25AM
07:35AM
07:10AM
07:06AM
06:00AM
Nov-04-24 07:00PM
04:16PM
04:10PM
04:00PM
03:30PM
01:34PM
12:31PM
12:08PM
10:39AM
09:53AM
09:36AM
09:30AM
09:18AM
08:12AM
07:34AM
07:06AM
07:00AM
05:13AM
04:48AM
Nov-03-24 07:00AM
Nov-02-24 12:00PM
09:47AM
Nov-01-24 05:30PM
04:08PM
02:24PM
09:35AM
09:12AM
08:13AM
06:45AM
Oct-31-24 04:15PM
Oct-30-24 02:32PM
12:57PM
11:22AM
08:30AM
07:18AM
07:02AM
05:45AM
Oct-29-24 09:18AM
07:05AM
05:07AM
Oct-28-24 05:45PM
04:29PM
09:00AM
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.